Clinical Trials on Myositis, Inclusion Body in Australia

Total 273 results

Abcuro, Inc.

Active, not recruiting

A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM)

Inclusion Body Myositis

Australia
University of Kansas Medical Center
The Perron Institute

Recruiting

Phase III Trial of Sirolimus in IBM

Inclusion Body Myositis

United States, Australia
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients (RESILIENT)

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Novartis Pharmaceuticals

Completed

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
Abcuro, Inc.
Syneos Health

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Inclusion Body Myositis

United States, Australia, Belgium, France, Canada, Germany, United Kingdom
Clementia Pharmaceuticals Inc.

Completed

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

Fibrodysplasia Ossificans Progressiva

United States, Argentina, Australia, France, United Kingdom
Clementia Pharmaceuticals Inc.

Completed

A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

Fibrodysplasia Ossificans Progressiva

United States, Argentina, Australia, France, United Kingdom, Italy
Ipsen

Active, not recruiting

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies. (PIVOINE)

Fibrodysplasia Ossificans Progressiva (FOP)

United States, France, Australia, Argentina, Italy, Canada, Sweden, United Kingdom, Brazil, Spain
Clementia Pharmaceuticals Inc.
Ipsen

Recruiting

A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). (FALKON)

Fibrodysplasia Ossificans Progressiva

United States, Korea, Republic of, Belgium, China, Sweden, France, Japan, Argentina, Australia, Brazil, Canada, Italy, Spain, United Kingdom, Mexico, Colombia, Netherlands, Germany, Portugal
Viking Therapeutics, Inc.

Recruiting

Phase 1 Study to Evaluate the Safety and Tolerability of VK2735

Weight Loss | NASH

Australia
Clementia Pharmaceuticals Inc.

Completed

An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva. (MOVE)

Fibrodysplasia Ossificans Progressiva

United States, Canada, France, Australia, Argentina, Brazil, Italy, Japan, Spain, Sweden, United Kingdom
Regeneron Pharmaceuticals

Recruiting

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP) (OPTIMA)

Fibrodysplasia Ossificans Progressiva

Japan, United States, Korea, Republic of, Spain, France, Australia, United Kingdom, China, Poland, Malaysia, Italy, Finland, Hong Kong, South Africa, Chile, Brazil, Netherlands, Colombia
University of Adelaide
Royal Adelaide Hospital

Unknown

Weight Loss Effects on Heart and Blood Vessel Function in Obesity

Obesity

Australia
Queensland Centre for Gynaecological Cancer

Completed

Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery

Cancer

Australia
Oslo University Hospital

Recruiting

TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS) (TenCRAOS)

Central Retinal Artery Occlusion

Denmark, Norway, Belgium, Sweden, Finland, Ireland, Lithuania, Australia, Austria
Vienna Institute for Research in Ocular Surgery

Completed

Reconstruction of Pathological Changes of the Ophthalmic Artery in Patients With Retinal Artery Occlusion

Retinal Artery Occlusion

Austria
NGM Biopharmaceuticals, Inc

Completed

Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects

Cachexia

Australia
Fremantle Hospital and Health Service

Completed

Tolerability, Efficacy and Mucosal Inflammation Associated With Orally Administered Colon Cleansing for Colonoscopy

Colonoscopy

Australia
Incyte Corporation

Recruiting

To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva (Progress)

Fibrodysplasia Ossificans Progressiva (FOP)

United States, France, Korea, Republic of, Spain, Italy, United Kingdom, Russian Federation, China, Australia, Brazil, Mexico, New Zealand, Argentina, Canada, Netherlands, Turkey, Chile, Germany, South Africa, Portugal
Oncocross Australia Pty Ltd.

Completed

A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514

Cancer Cachexia

Australia
University of Melbourne

Completed

Investigating Physiological Adaptations to Weight Loss

Obesity

Australia
Bristol-Myers Squibb

Completed

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Dermatomyositis | Polymyositis | Autoimmune Necrotizing Myopathy | Overlap Myositis | Juvenile Myositis Above the Age of 18

France, United States, Australia, Brazil, Czechia, Germany, Italy, Japan, Korea, Republic of, Mexico, Sweden
Rudolf Foundation Clinic

Completed

The ROVO Study: Radial Optic Neurotomy for CVO

Central Retinal Vein Occlusion

Austria
CSL Behring

Terminated

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Oral Mucositis

United States, Canada, Australia, Germany, Italy, Austria
Ethicon Endo-Surgery

Completed

Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety

Morbid Obesity

Czech Republic, Australia
Medical University of Vienna

Completed

Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Austria
University of Wollongong
National Centre of Excellence in Functional Foods, Australia

Unknown

Effectiveness of High Protein Diets in Promoting Weight Loss in Overweight and Obese Subjects.

Overweight

Australia
University of Melbourne

Recruiting

Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke (POST-ETERNAL)

Basilar Artery Occlusion

Australia
Zafgen, Inc.

Completed

An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects

Obesity

Australia
University of Adelaide
Commonwealth Scientific and Industrial Research Organisation, Australia; Isagenix... and other collaborators

Completed

AVocAdo Extract to Improve gLycemia in Individuals With Obesity (AVAIL)

Obesity

Australia
Okogen

Active, not recruiting

OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis (RUBY)

Adenoviral Conjunctivitis

Australia
Medical University of Vienna

Unknown

Skin Incision Skewness at Cesarean Section

Cesarean Section

Austria
Medical University of Vienna

Recruiting

Assessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects

Branch Retinal Vein Occlusion | Retinal Blood Flow | Retinal Oxygen Saturation

Austria
Gmax Biopharm Australia Pty Ltd.

Completed

Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106

Overweight and Obesity

Australia
Amgen

Recruiting

A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)

Idiopathic Inflammatory Myositis

Mexico, United States, Spain, Australia, Italy, United Kingdom, Czechia, Brazil, Germany
Pfizer
University of Adelaide; Royal Adelaide Hospital

Completed

Methods Study to Characterize Early Indicators of Weight Loss in People

Obesity

Australia
Ripple Therapeutics Pty Ltd
Novotech (Australia) Pty Limited

Active, not recruiting

Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy

Diabetic Macular Oedema | Retinal Vein Occlusion With Macular Oedema

Australia, New Zealand, Hong Kong, Canada
University of Manitoba
University of South Australia

Completed

Impact of Pulse-enriched Foods on Cognitive Function and Cardiometabolic Health in Obese Adults (PULSA-2011)

Obesity

Canada, Australia
Olivia Newton-John Cancer Research Institute
Austin Health; La Trobe University

Recruiting

Medical Imaging of Cachexia

Cancer Cachexia

Australia
North Eastern Weight Loss Surgery
Ethicon Endo-Surgery

Unknown

Outcomes of Gastric Band Fills as Found With a Patient Self-reported Questionnaire: The Vomiting, Eating, and Weight Loss (VEW) Questionnaire

Morbid Obesity

Australia
BaroNova, Inc.

Completed

A Study of the TransPyloric Shuttle™ (TPS™) for Weight Reduction in Obese Subjects

Obesity

Australia
NeuroSave Inc.

Completed

Targeted Hypothermia During Cardiac Surgery

Cardiac Surgery

Australia
Helsinn Healthcare SA

Withdrawn

Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer

Cancer Patients With Cachexia

Australia
Baker Heart Research Institute

Unknown

The Effects of Weight Loss on Neuroadrenergic Function

Obesity | Metabolic Syndrome | Type 2 Diabetes

Australia
Royal Perth Hospital
The University of Western Australia

Recruiting

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension (OHT)

Hypertension | Obesity

Australia
University of Melbourne

Completed

Effects of a Weight Loss Program in People With Hip Osteoarthritis (ECHO)

Hip Osteoarthritis | Overweight and Obesity

Australia
Women's and Children's Hospital, Australia
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Optimising Protection for Pregnant Women and Infants With Maternal Vaccination (OPTIWIN)

Obesity

Australia
University of Adelaide
Salk Institute for Biological Studies

Terminated

Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? (RESHAPE2)

Insulin Resistance | Type2 Diabetes

Australia
University of Melbourne

Completed

Effects of a Physiotherapist-delivered Dietary Weight Loss Program in People With Knee OA Who Have Overweight/Obesity

Knee Osteoarthritis | Overweight and Obesity

Australia
University of Adelaide
Central Adelaide Local Health Network Incorporated

Unknown

Quality of Life After Bariatric Surgery

Quality of Life | Obesity | Obesity, Morbid | Bariatric Surgery Candidate

Australia

Clinical Trials on Myositis, Inclusion Body in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations